Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction

Abstract The COVID-19 pandemic has resulted in an urgent need for a rapid, point of care diagnostic testing that could be rapidly scaled on a worldwide level. We developed and tested a highly sensitive and robust assay based on reverse transcription loop mediated isothermal amplification (RT-LAMP) t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shan Wei, Esther Kohl, Alexandre Djandji, Stephanie Morgan, Susan Whittier, Mahesh Mansukhani, Eldad Hod, Mary D’Alton, Yousin Suh, Zev Williams
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6d182b455806472a8759a067b2e4669f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6d182b455806472a8759a067b2e4669f
record_format dspace
spelling oai:doaj.org-article:6d182b455806472a8759a067b2e4669f2021-12-02T13:57:37ZDirect diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction10.1038/s41598-021-81487-y2045-2322https://doaj.org/article/6d182b455806472a8759a067b2e4669f2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81487-yhttps://doaj.org/toc/2045-2322Abstract The COVID-19 pandemic has resulted in an urgent need for a rapid, point of care diagnostic testing that could be rapidly scaled on a worldwide level. We developed and tested a highly sensitive and robust assay based on reverse transcription loop mediated isothermal amplification (RT-LAMP) that uses readily available reagents and a simple heat block using contrived spike-in and actual clinical samples. RT-LAMP testing on RNA-spiked samples showed a limit of detection (LoD) of 2.5 copies/μl of viral transport media. RT-LAMP testing directly on clinical nasopharyngeal swab samples in viral transport media had an 85% positive percentage agreement (PPA) (17/20), and 100% negative percentage agreement (NPV) and delivered results in 30 min. Our optimized RT-LAMP based testing method is a scalable system that is sufficiently sensitive and robust to test for SARS-CoV-2 directly on clinical nasopharyngeal swab samples in viral transport media in 30 min at the point of care without the need for specialized or proprietary equipment or reagents. This cost-effective and efficient one-step testing method can be readily available for COVID-19 testing world-wide, especially in resource poor settings.Shan WeiEsther KohlAlexandre DjandjiStephanie MorganSusan WhittierMahesh MansukhaniEldad HodMary D’AltonYousin SuhZev WilliamsNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shan Wei
Esther Kohl
Alexandre Djandji
Stephanie Morgan
Susan Whittier
Mahesh Mansukhani
Eldad Hod
Mary D’Alton
Yousin Suh
Zev Williams
Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction
description Abstract The COVID-19 pandemic has resulted in an urgent need for a rapid, point of care diagnostic testing that could be rapidly scaled on a worldwide level. We developed and tested a highly sensitive and robust assay based on reverse transcription loop mediated isothermal amplification (RT-LAMP) that uses readily available reagents and a simple heat block using contrived spike-in and actual clinical samples. RT-LAMP testing on RNA-spiked samples showed a limit of detection (LoD) of 2.5 copies/μl of viral transport media. RT-LAMP testing directly on clinical nasopharyngeal swab samples in viral transport media had an 85% positive percentage agreement (PPA) (17/20), and 100% negative percentage agreement (NPV) and delivered results in 30 min. Our optimized RT-LAMP based testing method is a scalable system that is sufficiently sensitive and robust to test for SARS-CoV-2 directly on clinical nasopharyngeal swab samples in viral transport media in 30 min at the point of care without the need for specialized or proprietary equipment or reagents. This cost-effective and efficient one-step testing method can be readily available for COVID-19 testing world-wide, especially in resource poor settings.
format article
author Shan Wei
Esther Kohl
Alexandre Djandji
Stephanie Morgan
Susan Whittier
Mahesh Mansukhani
Eldad Hod
Mary D’Alton
Yousin Suh
Zev Williams
author_facet Shan Wei
Esther Kohl
Alexandre Djandji
Stephanie Morgan
Susan Whittier
Mahesh Mansukhani
Eldad Hod
Mary D’Alton
Yousin Suh
Zev Williams
author_sort Shan Wei
title Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction
title_short Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction
title_full Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction
title_fullStr Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction
title_full_unstemmed Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction
title_sort direct diagnostic testing of sars-cov-2 without the need for prior rna extraction
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6d182b455806472a8759a067b2e4669f
work_keys_str_mv AT shanwei directdiagnostictestingofsarscov2withouttheneedforpriorrnaextraction
AT estherkohl directdiagnostictestingofsarscov2withouttheneedforpriorrnaextraction
AT alexandredjandji directdiagnostictestingofsarscov2withouttheneedforpriorrnaextraction
AT stephaniemorgan directdiagnostictestingofsarscov2withouttheneedforpriorrnaextraction
AT susanwhittier directdiagnostictestingofsarscov2withouttheneedforpriorrnaextraction
AT maheshmansukhani directdiagnostictestingofsarscov2withouttheneedforpriorrnaextraction
AT eldadhod directdiagnostictestingofsarscov2withouttheneedforpriorrnaextraction
AT marydalton directdiagnostictestingofsarscov2withouttheneedforpriorrnaextraction
AT yousinsuh directdiagnostictestingofsarscov2withouttheneedforpriorrnaextraction
AT zevwilliams directdiagnostictestingofsarscov2withouttheneedforpriorrnaextraction
_version_ 1718392265374695424